Functional Neurological Disorder (FND) Research Group

Our research focusses on Functional Neurological Disorders (FND), formerly called Conversion disorder. They consist of a neurological dysfunction that occurs in the absence of a classical neurological disease or lesions of the nervous system, but is distinct from other major psychiatric symptoms.

Our team is multidisciplinary, involving neurologists, engineers, psychologists and neuroscientists so that we can merge our expertise in conducting clinical research, aiming to better understand this disabling disorder and ultimately help the numerous patients suffering from FND.

An important part of our research is dedicated to the validation of clinical bedside signs in order to aid the diagnostic process, the identification of biomarkers  (objective assessment of clinical signs, brain MRI) and epidemiologic surveys in order to define prognostic factors.

Another important part of our research aims at a better understanding of the links between stress, emotion regulation and the physical symptoms, by studying biological markers of the stress response (cortisol, alpha-amylase, motor freeze response and brain activity under stress).

 

Research

  • AR/VR Study

    The sense of agency (SoA) is a fundamental aspect of human self-consciousness that allows us to make judgements about whether we did something ourselves or not. A disturbed SoA was often found in patients with FND. Additionally, patients with FND show a mechanism of increased self-monitoring – i.e., FND patients focus more on their affected limbs than their environment. Thus, FND patients experience a constant “nocebo” effect. This increased attention may maintain the patient’s expectation that they cannot control their body, which in turn maintains poor motor performance.

     

    In the ARVR study, we explore the SoA and self-monitoring in FND patients within a Virtual/Augmented Reality (VR/AR) environment implementing video-eye-oculography. This study will shed light on the visual focus of attention of FND patients during a cognitive motor task in relation to their motor symptoms.

  • fMRI study

    Sense of agency and prior beliefs are two cognitive processes describing, respectively, the sense of control over voluntary actions, and the processing of priors to explain sensory input. Evidence for an online component of these processes, during action execution, and an offline one, during retrospective thinking about that action, has been described. Neuroimaging studies of online agency showed activity in visuo-motor and parietal areas when the sense of agency was disrupted. The networks of offline agency and prior beliefs have received little attention.

     

    The aim of the fMRI study is to test the neural correlates of agency and prior belief, in patients affected by functional neurological disorders and healthy controls.

     

    We engage FND patients and healthy controls in a motor task where we artificially manipulate sense of agency and prior beliefs, under functional magnetic resonance imaging (fMRI). In the task, first participants first perform a simple game (online phase), and then judge their performance and sense of control over it (offline phase).

  • Interoception study
    Schappelle, CC BY-SA

    Interoception describes the signals coming from internal organs such as the heart or gut. This sensory modality has been of interest in various medical and psychiatric research and seems to be highly relevant for FND as well.

    The aim of our project is to test the interoceptive performance of FND patients using a variety of tasks and to compare these with those of healthy controls (HC). We will include both traditionally used and newly developed explicit tasks, as well as implicit measures using an electroencephalogram (EEG). The tasks will provide scores that can be interpreted under the Bayesian Brain hypothesis by providing scores for predictive coding and interoceptive precision weighting. We will also assess trait and metacognition as a central component to complete the conceptual model of the Bayesian Brain. Finally, we will also investigate how biological components, such as the neuropeptide oxytocin, may play a key role in the precision weighting of interoceptive signals.

    Overall, this study provides a novel approach to the pathophysiology of FND by incorporating concepts from computational neuroscience, biological components and psychosocial risk factors.

  • Agency studies

    Current neuroscientific models suggest that FND symptoms have a common underlying mechanism: the loss of control over voluntary movement, also known as agency.

    In our studies, we seek to better understand and characterise these impairments of full-body agency using virtual reality (VR) and body motion tracking. To do this, we have used experiments designed to test multisensory integration in bodily self-awareness. For example, we will compare the performance of FND patients and healthy controls to identify with a virtual avatar if they react differently to their own movements.

    These projects will allow improving the characterization and understanding of FND symptoms.

  • Sex hormones and FND

    Major hormonal changes across life—such as those occurring during puberty, pregnancy, postpartum, and menopause—are known to strongly influence brain function and the course of many neurological and psychiatric conditions. For instance, migraine often improves during pregnancy, multiple sclerosis relapse rates can shift after childbirth, and mood disorders are closely linked to hormonal transitions. In functional neurological disorder (FND), however, the role of these hormonal events has barely been studied, even though FND disproportionately affects women, with a gender ratio of about 1:3. To begin addressing this gap, we are running an international survey distributed through healthcare professionals. The survey asks people with FND whether they noticed changes in their symptoms after specific hormonal events, such as starting or stopping hormonal contraception, becoming pregnant, or reaching menopause. We are also gathering insights from individuals who have undergone gender transition, as very little is known about how hormone treatment in this context may affect FND. This project aims to build the first large-scale picture of how hormonal life events may shape the course of FND, opening the door to new directions for research and clinical care.

  • Menstrual cycle project

    The menstrual cycle is characterized by striking hormonal fluctuations, particularly in estrogen and progesterone, which are known to influence brain function and behavior. These cyclical changes have been shown to play an important role in several neurological conditions—for example, some women with multiple sclerosis experience shifts in relapse rates across their cycle, while in epilepsy, certain seizure patterns are closely tied to hormonal phases. Despite this, we know almost nothing about how the menstrual cycle affects people with functional neurological disorder (FND). To investigate this, our study invites participants with regular cycles to attend two visits: one in the premenstrual phase and another after menstruation. During each visit, participants undergo a neurological examination, brain imaging with fMRI, and a series of cognitive tasks. By comparing these two time points, we aim to uncover whether hormonal shifts across the cycle contribute to changes in FND symptoms and brain activity, shedding light on a potential biological mechanism that has so far been overlooked.

  • TMS-VNS project

    The main goal of this project is to evaluate the feasibility and potential beneficial effects of Vagus Nerve Stimulation (VNS) on the quality of life in FND (Functional Neurological Disorder), which has shown promising results in other motor disorders, such as stroke and Parkinson’s disease. In addition, we investigate the mechanisms linked to this potential therapy at the neurophysiological level (using Transcranial Magnetic Stimulation -TMS) and at the neuroimaging level (using functional magnetic resonance imaging - fMRI).

    The VNS is done with a small electrode in the patient’s ear like an earplug. The device is portable and delivers non-invasive stimulation of the vagus nerve. Patients will follow their usual physiotherapy session with it.

Address: 

Selma Aybek
Neurology unit
chemin du Musée 5
1700 Fribourg